PCI Pharma Services: White Papers

Seamless CDMO solutions
Tuesday, February 07, 2023 With the number of registered clinical trials increasing significantly each year, it’s not surprising to learn that the clinical trials supply and logistics market is predicted to...

Cutting edge fill-finish solutions
Tuesday, January 24, 2023 Utilising the latest advancements of the Microcell and SA25 technologies, PCI Pharma Services delivers flexible aseptic fill-finish solutions for both small and larger-scale...

Biologics and Specialty Medicines: Planning Your Packaging for a Seamless Transition from Clinic to Launch
Wednesday, October 19, 2022 The pharmaceutical landscape continues to evolve with an ever-increasing focus on specialty medicines. As a result, supply chains are becoming more complex, driven by factors such as...

Planning for Return and Destruction
Wednesday, October 19, 2022 Annex I, states that a clinical protocol shall include “a description of the arrangements for tracing, storing, destroying and returning the investigational medicinal product...

Why Robotic Sterile Fill-Finish is Key for Speed to Clinic and Patient Safety
Wednesday, October 19, 2022 Sterile fill-finish is a mainstay in pharmaceutical manufacturing, and robotic platforms will be a true differentiator. This latest article from PCI discusses robotic sterile...

Product return and destruction
Friday, August 12, 2022

Executive Q&A on Driving Digital Transformation in the Pharma Industry
Monday, February 28, 2022 As a respected industry leader and trusted partner, PCI Pharma Services provides a comprehensive range of pharmaceutical services from the earliest stages of drug development through...

Navigating the New EU Clinical Trial Regulation
Monday, February 28, 2022 PCI Clinical Trial Services hosts a weekly “Virtual Water Cooler Chat” series, where our subject matter experts host informal discussions around a number of clinical supply “hot topics.”

Delivering the Full Value Chain for Oncology Clinical Trials
Monday, February 28, 2022 The incidence of cancer is increasing across the globe, and pharmaceutical companies are responding with a pipeline of novel therapeutic candidates. Oncology clinical trials are...

An Evolving Biologics Landscape and Driving Innovation and Opportunity
Monday, February 28, 2022 The biologics segment, already growing in importance before the COVID-19 pandemic, is expanding even faster in its wake with respect to both the level of investment and number of...

A game-changing digital platform
Friday, January 28, 2022 The pharmaceutical industry has historically been risk-averse and slow to adopt technology. PCI Pharma Services is blazing a trail in digitalisation.

Precision micro-dosing for clinical development
Thursday, July 15, 2021

A game-changing digital platform
Friday, April 16, 2021

Adaptive drug supply
Friday, August 28, 2020 There are many factors that can derail trials, which is why adaptive clinical trial designs are a good solution to allow for unforeseen data results. It is clinical trial...

PCI_Importing Clinical Supplies into China
Friday, August 14, 2020

Tuesday, August 04, 2020

PCI The Final Mile for European Compassionate Use Programs
Tuesday, August 04, 2020

Importing Clinical Supplies into Japan
Tuesday, August 04, 2020

PCI Speed to Study brochure rebrand
Tuesday, August 04, 2020

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.